• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Memantine rescues transient cognitive impairment caused by high-molecular-weight aβ oligomers but not the persistent impairment induced by low-molecular-weight oligomers.美金刚可挽救由高分子量β淀粉样蛋白寡聚物引起的短暂认知障碍,但不能挽救由低分子量寡聚物引起的持续损害。
J Neurosci. 2013 Jun 5;33(23):9626-34. doi: 10.1523/JNEUROSCI.0482-13.2013.
2
Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.NR2B 含 NMDA 受体和 mGluR5 代谢型谷氨酸受体在介导 β-淀粉样寡聚体对小鼠海马切片长时程增强(LTP)的突触毒性作用中的治疗意义。
Neuropharmacology. 2011 May;60(6):982-90. doi: 10.1016/j.neuropharm.2011.01.051. Epub 2011 Feb 12.
3
Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity.靶向淀粉样β1-42寡聚体的阿尔茨海默病治疗方法II:Sigma-2/PGRMC1受体介导β淀粉样蛋白42寡聚体的结合和突触毒性。
PLoS One. 2014 Nov 12;9(11):e111899. doi: 10.1371/journal.pone.0111899. eCollection 2014.
4
Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate.来自阿尔茨海默病大脑的淀粉样β蛋白的大可溶性寡聚体的神经活性远低于它们解离形成的较小寡聚体。
J Neurosci. 2017 Jan 4;37(1):152-163. doi: 10.1523/JNEUROSCI.1698-16.2016.
5
Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.靶向淀粉样β-蛋白1-42寡聚体的阿尔茨海默病治疗方法I:药物候选物可取代与特定神经元受体结合的β-淀粉样蛋白42寡聚体,从而改善认知缺陷。
PLoS One. 2014 Nov 12;9(11):e111898. doi: 10.1371/journal.pone.0111898. eCollection 2014.
6
Interaction of amyloid-β (Aβ) oligomers with neurexin 2α and neuroligin 1 mediates synapse damage and memory loss in mice.淀粉样蛋白β(Aβ)寡聚体与神经连接蛋白2α和神经配蛋白1的相互作用介导了小鼠的突触损伤和记忆丧失。
J Biol Chem. 2017 May 5;292(18):7327-7337. doi: 10.1074/jbc.M116.761189. Epub 2017 Mar 10.
7
Interleukin-1β mediates alterations in mitochondrial fusion/fission proteins and memory impairment induced by amyloid-β oligomers.白细胞介素-1β介导淀粉样β寡聚体引起的线粒体融合/分裂蛋白改变和记忆障碍。
J Neuroinflammation. 2021 Feb 21;18(1):54. doi: 10.1186/s12974-021-02099-x.
8
MRZ-99030 - A novel modulator of Aβ aggregation: II - Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice.MRZ-99030 - 一种新型的β-淀粉样蛋白聚集调节剂:II - 逆转β-淀粉样蛋白寡聚体诱导的大鼠和小鼠长期增强(LTP)及认知能力缺陷
Neuropharmacology. 2015 May;92:170-82. doi: 10.1016/j.neuropharm.2014.12.037. Epub 2015 Jan 28.
9
Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice.普罗布考,一种降脂药物,可预防淀粉样β肽在小鼠体内引起的认知和海马突触损伤。
Exp Neurol. 2012 Feb;233(2):767-75. doi: 10.1016/j.expneurol.2011.11.036. Epub 2011 Dec 8.
10
Alzheimer's disease-like pathology induced by amyloid-β oligomers in nonhuman primates.非人灵长类动物中由β-淀粉样蛋白寡聚体诱导的阿尔茨海默病样病理变化。
J Neurosci. 2014 Oct 8;34(41):13629-43. doi: 10.1523/JNEUROSCI.1353-14.2014.

引用本文的文献

1
Chaperone-Mediated Responses and Mitochondrial-Endoplasmic Reticulum Coupling: Emerging Insight into Alzheimer's Disease.伴侣介导的反应与线粒体-内质网偶联:对阿尔茨海默病的新见解
Cells. 2025 Jul 31;14(15):1179. doi: 10.3390/cells14151179.
2
Doxorubicin Induces a Senescent Phenotype in Murine and Human Astrocytes.阿霉素在小鼠和人类星形胶质细胞中诱导衰老表型。
J Neurochem. 2025 Aug;169(8):e70177. doi: 10.1111/jnc.70177.
3
Aducanumab binds high molecular weight soluble Aβ oligomers and restores intracellular calcium levels.阿杜卡努单抗可结合高分子量可溶性β淀粉样蛋白寡聚体并恢复细胞内钙水平。
Alzheimers Res Ther. 2025 Aug 4;17(1):180. doi: 10.1186/s13195-025-01812-9.
4
Neuronal and Glial α7 Nicotinic Acetylcholine Receptors: Role in Alzheimer's Disease Pathophysiology.神经元和神经胶质细胞的α7烟碱型乙酰胆碱受体:在阿尔茨海默病病理生理学中的作用
Life (Basel). 2025 Jun 28;15(7):1032. doi: 10.3390/life15071032.
5
Neonatal maternal separation causes depressive-like behavior and potentiates memory impairment induced by amyloid-β oligomers in adult mice.新生鼠母婴分离会导致成年小鼠出现类似抑郁的行为,并加剧由β-淀粉样蛋白寡聚体诱导的记忆损伤。
Behav Brain Funct. 2025 Mar 20;21(1):8. doi: 10.1186/s12993-025-00266-1.
6
Inhibition of amyloid beta oligomer accumulation by NU-9: A unifying mechanism for the treatment of neurodegenerative diseases.NU-9对β-淀粉样蛋白寡聚体积累的抑制作用:一种治疗神经退行性疾病的统一机制。
Proc Natl Acad Sci U S A. 2025 Mar 11;122(10):e2402117122. doi: 10.1073/pnas.2402117122. Epub 2025 Mar 3.
7
Differences in pharmacologic and demographic factors in male and female patients with vascular dementia, Alzheimer's disease, and mixed vascular dementia.血管性痴呆、阿尔茨海默病和混合性血管性痴呆的男性和女性患者在药理学和人口统计学因素上的差异。
Front Dement. 2023 Jun 30;2:1137856. doi: 10.3389/frdem.2023.1137856. eCollection 2023.
8
Targeting soluble amyloid-beta oligomers with a novel nanobody.靶向可溶性淀粉样β寡聚体的新型纳米抗体。
Sci Rep. 2024 Jul 12;14(1):16086. doi: 10.1038/s41598-024-66970-6.
9
The ketamine metabolite (2R,6R)-hydroxynorketamine rescues hippocampal mRNA translation, synaptic plasticity and memory in mouse models of Alzheimer's disease.氯胺酮代谢物 (2R,6R)-羟基去甲氯胺酮可挽救阿尔茨海默病小鼠模型中海马的 mRNA 翻译、突触可塑性和记忆。
Alzheimers Dement. 2024 Aug;20(8):5398-5410. doi: 10.1002/alz.14034. Epub 2024 Jun 27.
10
TARGETING SOLUBLE AMYLOID-BETA OLIGOMERS WITH A NOVEL NANOBODY.用新型纳米抗体靶向可溶性淀粉样β寡聚体。
Res Sq. 2024 Mar 15:rs.3.rs-3944211. doi: 10.21203/rs.3.rs-3944211/v1.

本文引用的文献

1
The complex PrP(c)-Fyn couples human oligomeric Aβ with pathological tau changes in Alzheimer's disease.该复合物 PrP(c)-Fyn 将人类寡聚体 Aβ与阿尔茨海默病中的病理性 tau 变化偶联。
J Neurosci. 2012 Nov 21;32(47):16857-71a. doi: 10.1523/JNEUROSCI.1858-12.2012.
2
Preventing Alzheimer's disease.预防阿尔茨海默病。
Science. 2012 Sep 21;337(6101):1488-92. doi: 10.1126/science.1228541.
3
Selective impairment of some forms of synaptic plasticity by oligomeric amyloid-β peptide in the mouse hippocampus: implication of extrasynaptic NMDA receptors.寡聚淀粉样β肽在小鼠海马体中选择性损害某些形式的突触可塑性:细胞外 NMDA 受体的影响。
J Alzheimers Dis. 2012;32(1):183-96. doi: 10.3233/JAD-2012-120394.
4
Neurotoxicity of amyloid β-protein: synaptic and network dysfunction.β淀粉样蛋白的神经毒性:突触和网络功能障碍。
Cold Spring Harb Perspect Med. 2012 Jul;2(7):a006338. doi: 10.1101/cshperspect.a006338.
5
Neurotoxicity and memory deficits induced by soluble low-molecular-weight amyloid-β1-42 oligomers are revealed in vivo by using a novel animal model.新型动物模型揭示了可溶性低分子量淀粉样β1-42 寡聚物诱导的神经毒性和记忆缺陷。
J Neurosci. 2012 Jun 6;32(23):7852-61. doi: 10.1523/JNEUROSCI.5901-11.2012.
6
Pharmacokinetics of memantine in rats and mice.美金刚在大鼠和小鼠体内的药代动力学。
PLoS Curr. 2011 Dec 15;3:RRN1291. doi: 10.1371/currents.RRN1291.
7
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes.有毒的 Aβ 寡聚体与阿尔茨海默病:一个需要穿衣服的皇帝。
Nat Neurosci. 2012 Jan 29;15(3):349-57. doi: 10.1038/nn.3028.
8
Amyloid-β oligomers induce differential gene expression in adult human brain slices.淀粉样β寡聚体诱导成人脑切片中的差异基因表达。
J Biol Chem. 2012 Mar 2;287(10):7436-45. doi: 10.1074/jbc.M111.298471. Epub 2012 Jan 10.
9
Soluble Aβ oligomer production and toxicity.可溶性 Aβ 寡聚物的产生和毒性。
J Neurochem. 2012 Jan;120 Suppl 1(Suppl 1):125-139. doi: 10.1111/j.1471-4159.2011.07478.x. Epub 2011 Nov 28.
10
The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease.阿尔茨海默病中突触衰竭和记忆丧失的 Aβ 寡聚物假说。
Neurobiol Learn Mem. 2011 Nov;96(4):529-43. doi: 10.1016/j.nlm.2011.08.003. Epub 2011 Sep 6.

美金刚可挽救由高分子量β淀粉样蛋白寡聚物引起的短暂认知障碍,但不能挽救由低分子量寡聚物引起的持续损害。

Memantine rescues transient cognitive impairment caused by high-molecular-weight aβ oligomers but not the persistent impairment induced by low-molecular-weight oligomers.

机构信息

School of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, RJ 21944-590, Brazil.

出版信息

J Neurosci. 2013 Jun 5;33(23):9626-34. doi: 10.1523/JNEUROSCI.0482-13.2013.

DOI:10.1523/JNEUROSCI.0482-13.2013
PMID:23739959
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6619709/
Abstract

Brain accumulation of soluble amyloid-β oligomers (AβOs) has been implicated in synapse failure and cognitive impairment in Alzheimer's disease (AD). However, whether and how oligomers of different sizes induce synapse dysfunction is a matter of controversy. Here, we report that low-molecular-weight (LMW) and high-molecular-weight (HMW) Aβ oligomers differentially impact synapses and memory. A single intracerebroventricular injection of LMW AβOs (10 pmol) induced rapid and persistent cognitive impairment in mice. On the other hand, memory deficit induced by HMW AβOs (10 pmol) was found to be reversible. While memory impairment in LMW oligomer-injected mice was associated with decreased hippocampal synaptophysin and GluN2B immunoreactivities, synaptic pathology was not detected in the hippocampi of HMW oligomer-injected mice. On the other hand, HMW oligomers, but not LMW oligomers, induced oxidative stress in hippocampal neurons. Memantine rescued both neuronal oxidative stress and the transient memory impairment caused by HMW oligomers, but did not prevent the persistent cognitive deficit induced by LMW oligomers. Results establish that different Aβ oligomer assemblies act in an orchestrated manner, inducing different pathologies and leading to synapse dysfunction. Furthermore, results suggest a mechanistic explanation for the limited efficacy of memantine in preventing memory loss in AD.

摘要

脑内可溶性淀粉样β寡聚物(AβOs)的积累与阿尔茨海默病(AD)中的突触功能障碍和认知障碍有关。然而,不同大小的寡聚物是否以及如何诱导突触功能障碍仍存在争议。在这里,我们报告低分子量(LMW)和高分子量(HMW)Aβ寡聚物对突触和记忆有不同的影响。单次侧脑室注射 LMW AβOs(10 pmol)可迅速引起小鼠持续的认知障碍。另一方面,我们发现 HMW AβOs(10 pmol)引起的记忆缺陷是可逆的。虽然 LMW 寡聚物注射小鼠的记忆损伤与海马突触小体素和 GluN2B 免疫反应性降低有关,但在 HMW 寡聚物注射小鼠的海马中未检测到突触病变。另一方面,HMW 寡聚物而非 LMW 寡聚物诱导海马神经元的氧化应激。美金刚可同时挽救 HMW 寡聚物引起的神经元氧化应激和短暂的记忆损伤,但不能预防 LMW 寡聚物引起的持续认知缺陷。结果表明,不同的 Aβ寡聚物组装以协调的方式发挥作用,诱导不同的病理学并导致突触功能障碍。此外,结果为美金刚预防 AD 中记忆丧失的有限疗效提供了一种机制解释。